FDA Drug Application (021121) for CONCERTA by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number021121
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage18MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCONCERTA
Active IngredientMETHYLPHENIDATE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient METHYLPHENIDATE HYDROCHLORIDE12


Back to FDA Applications sponsored by JANSSEN PHARMS